249 related articles for article (PubMed ID: 23864703)
1. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly men and women.
Durosier C; van Lierop A; Ferrari S; Chevalley T; Papapoulos S; Rizzoli R
J Clin Endocrinol Metab; 2013 Sep; 98(9):3873-83. PubMed ID: 23864703
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
Ishimura E; Okuno S; Ichii M; Norimine K; Yamakawa T; Shoji S; Nishizawa Y; Inaba M
J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults.
Amrein K; Amrein S; Drexler C; Dimai HP; Dobnig H; Pfeifer K; Tomaschitz A; Pieber TR; Fahrleitner-Pammer A
J Clin Endocrinol Metab; 2012 Jan; 97(1):148-54. PubMed ID: 21994959
[TBL] [Abstract][Full Text] [Related]
4. Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure.
Bonnet N; Biver E; Durosier C; Chevalley T; Rizzoli R; Ferrari S
J Clin Endocrinol Metab; 2015 Jul; 100(7):E1014-21. PubMed ID: 25867813
[TBL] [Abstract][Full Text] [Related]
5. Serum sclerostin levels are decreased in adult patients with different types of osteogenesis imperfecta.
Kocijan R; Muschitz C; Fahrleitner-Pammer A; Amrein K; Pietschmann P; Haschka J; Dinu S; Kapiotis S; Resch H
J Clin Endocrinol Metab; 2014 Feb; 99(2):E311-9. PubMed ID: 24203063
[TBL] [Abstract][Full Text] [Related]
6. Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.
Szulc P; Boutroy S; Vilayphiou N; Schoppet M; Rauner M; Chapurlat R; Hamann C; Hofbauer LC
J Bone Miner Res; 2013 Aug; 28(8):1760-70. PubMed ID: 23408601
[TBL] [Abstract][Full Text] [Related]
7. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin in institutionalized elderly women: associations with quantitative bone ultrasound, bone turnover, fractures, and mortality.
Amrein K; Dobnig H; Wagner D; Piswanger-Sölkner C; Pieber TR; Pilz S; Tomaschitz A; Dimai HP; Fahrleitner-Pammer A
J Am Geriatr Soc; 2014 Jun; 62(6):1023-9. PubMed ID: 24779429
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients.
Cejka D; Jäger-Lansky A; Kieweg H; Weber M; Bieglmayer C; Haider DG; Diarra D; Patsch JM; Kainberger F; Bohle B; Haas M
Nephrol Dial Transplant; 2012 Jan; 27(1):226-30. PubMed ID: 21613383
[TBL] [Abstract][Full Text] [Related]
10. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
He J; Zhang H; Wang C; Zhang Z; Yue H; Hu W; Gu J; Fu W; Hu Y; Li M; Liu Y; Zheng H; Zhang Z
J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
[TBL] [Abstract][Full Text] [Related]
11. Serum sclerostin levels in men with idiopathic osteoporosis.
Lapauw B; Vandewalle S; Taes Y; Goemaere S; Zmierczak H; Collette J; Kaufman JM
Eur J Endocrinol; 2013 Apr; 168(4):615-20. PubMed ID: 23389587
[TBL] [Abstract][Full Text] [Related]
12. Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5.
Frost M; Andersen T; Gossiel F; Hansen S; Bollerslev J; van Hul W; Eastell R; Kassem M; Brixen K
J Bone Miner Res; 2011 Aug; 26(8):1721-8. PubMed ID: 21351148
[TBL] [Abstract][Full Text] [Related]
13. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
[TBL] [Abstract][Full Text] [Related]
14. Preeclampsia - a risk factor for osteoporosis? Analysis of maternal Sclerostin levels and markers of bone turnover in patients with pre-eclampsia.
Wild J; Pateisky P; Küssel L; Huf W; Ott J; Haslinger P; Knöfler M; Zeisler H
Hypertens Pregnancy; 2014 Aug; 33(3):333-40. PubMed ID: 24568269
[TBL] [Abstract][Full Text] [Related]
15. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
[TBL] [Abstract][Full Text] [Related]
16. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
Pelletier S; Confavreux CB; Haesebaert J; Guebre-Egziabher F; Bacchetta J; Carlier MC; Chardon L; Laville M; Chapurlat R; London GM; Lafage-Proust MH; Fouque D
Osteoporos Int; 2015 Aug; 26(8):2165-74. PubMed ID: 25910747
[TBL] [Abstract][Full Text] [Related]
17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
18. Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus.
Neumann T; Hofbauer LC; Rauner M; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Hamann C; Sämann A
Clin Endocrinol (Oxf); 2014 May; 80(5):649-55. PubMed ID: 24237244
[TBL] [Abstract][Full Text] [Related]
19. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
Costa AG; Walker MD; Zhang CA; Cremers S; Dworakowski E; McMahon DJ; Liu G; Bilezikian JP
J Clin Endocrinol Metab; 2013 Dec; 98(12):4736-43. PubMed ID: 24037879
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes.
Fazeli PK; Ackerman KE; Pierce L; Guereca G; Bouxsein M; Misra M
Osteoporos Int; 2013 Sep; 24(9):2433-40. PubMed ID: 23579340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]